Current approaches to diagnosing in intracerebral hemorrhage
https://doi.org/10.14412/2074-2711-2020-2-4-11
Abstract
Intracerebral hemorrhage (ICH) is the same etiologically heterogeneous variant of stroke as cerebral infarction. The most common causes of the disease are hypertensive and cerebral amyloid microangiopathy, the use of oral anticoagulants (OACs) and their combination, and arteriovenous malformations, which are of the greatest importance for young patients. The SMASH-U or H-ATOMIC classification of ICH requires a structured diagnostic search that includes an analysis of the clinical presentations of the disease and neuroimaging and angiographic findings. Although brain computed tomography remains a basic diagnostic technique for ICH, most patients need brain magnetic resonance imaging, by mandatorily assessing the ischemic and hemorrhagic markers of cerebral small vessel diseases. This examination is necessary not only to verify the cause of ICH and to select the appropriate method of its treatment, but also to determine the risk of recurrent hemorrhage. The article considers the epidemiology and etiological characteristics of ICH and approaches to its classification. It characterizes the most significant causes of the disease, such as hypertensive and cerebral amyloid angiopathy, vessel structural abnormalities, and the use of OACs. The
diagnosis of ICH and its clinical neuroimaging diagnostic algorithm are presented.
diagnosis of ICH and its clinical neuroimaging diagnostic algorithm are presented.
About the Author
A. A. Kulesh
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia
Russian Federation
2, Kim St., Perm 614107, Russia
Russian Federation
2, Kim St., Perm 614107, Russia
References
1. Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.
2. Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.
3. An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.
4. An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.
5. Marti-Fabregas J, Prats-Sanchez L, Martinez-Domeno A, et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992.eCollection 2016.
6. Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6.
7. Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.
8. Cordonnier C, Demchuk A, Ziai W, Anderson CS. Intracerebral haemorrhage: current approaches to acute management. Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6.
9. van Asch CJ, Velthuis BK, Rinkel GJ, et al; DIAGRAM Investigators. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.
10. Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019 Jul;19(7):679-694. doi: 10.1080/14737175.2019.1623671. Epub 2019 Jun 12.
11. Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019 Jul;19(7):679-694. doi: 10.1080/14737175.2019.1623671. Epub 2019 Jun 12.
12. Pasi M, Charidimou A, Boulouis G, et al. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.
13. Parfenov VA. Poststroke cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):22-7. (In Russ.) doi: 10.14412/2074-2711-2019-4-22-27
14. Parfenov VA. Poststroke cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):22-7. (In Russ.) doi: 10.14412/2074-2711-2019-4-22-27
15. Kalashnikova LA, Gulevskaya TS, Dobrynina LA. Current problems of brain pathology in cerebral microangiopathy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 118(2):90-9. (In Russ.)
16. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17.
17. O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study. Lancet. 2010 Jul 10;376(9735):112-23. doi: 10.1016/S0140-6736(10)60834-3. Epub 2010 Jun 17.
18. Kulesh AA, Drobakha VE, Shestakov VV. Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4-17. (In Russ.) doi: 10.14412/2074-2711-2019-3S-4-17
19. Tatlisumak T, Cucchiara B, Kuroda S, et al. Nontraumatic intracerebral haemorrhage in young adults. Review. Nat Rev Neurol. 2018 Apr;14(4):237-250. doi: 10.1038/nrneurol.2018.17. Epub 2018 Mar 9.
20. Tatlisumak T, Cucchiara B, Kuroda S, et al. Nontraumatic intracerebral haemorrhage in young adults. Review. Nat Rev Neurol. 2018 Apr;14(4):237-250. doi: 10.1038/nrneurol.2018.17. Epub 2018 Mar 9.
21. Novosadova OA, Grigor'eva VN. Cerebral amyloid angiopathy and hypertensive cerebral microangiopathy. Differential diagnosis. Nevrologicheskii vestnik. 2019;51(2):72-9. (In Russ.)
22. Gross BA, Jankowitz BT, Friedlander RM. Cerebral Intraparenchymal Hemorrhage: A Review. JAMA. 2019 Apr 2;321(13): 1295-1303. doi: 10.1001/jama.2019.2413.
23. Gross BA, Jankowitz BT, Friedlander RM. Cerebral Intraparenchymal Hemorrhage: A Review. JAMA. 2019 Apr 2;321(13): 1295-1303. doi: 10.1001/jama.2019.2413.
24. Perry LA, Rodrigues M, Al-Shahi Salman R, Samarasekera N. Incident Cerebral Microbleeds After Intracerebral Hemorrhage. Stroke. 2019 Aug;50(8):2227-2230. doi: 10.1161/STROKEAHA.118.023746. Epub 2019 Jun 17.
25. Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.
26. Meretoja A, Strbian D, Putaala J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012 Oct;43(10):2592-7. Epub 2012 Aug 2.
27. Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4.
28. Marti-Fabregas J, Prats-Sanchez L, Martinez-Domeno A, et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992.eCollection 2016.
29. Marti-Fabregas J, Prats-Sanchez L, Martinez-Domeno A, et al. The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992.eCollection 2016.
30. Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.
31. van Asch CJ, Velthuis BK, Rinkel GJ, et al; DIAGRAM Investigators. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.
32. van Asch CJ, Velthuis BK, Rinkel GJ, et al; DIAGRAM Investigators. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ. 2015 Nov 9;351:h5762. doi: 10.1136/bmj.h5762.
33. Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.
34. Pasi M, Charidimou A, Boulouis G, et al. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.
35. Pasi M, Charidimou A, Boulouis G, et al. Cerebral small vessel disease in patients with spontaneous cerebellar hemorrhage. J Neurol. 2019 Mar;266(3):625-630. doi: 10.1007/s00415-018-09177-w. Epub 2019 Jan 8.
36. Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37
37. Kalashnikova LA, Gulevskaya TS, Dobrynina LA. Current problems of brain pathology in cerebral microangiopathy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 118(2):90-9. (In Russ.)
38. Kalashnikova LA, Gulevskaya TS, Dobrynina LA. Current problems of brain pathology in cerebral microangiopathy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018; 118(2):90-9. (In Russ.)
39. Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34
40. Kulesh AA, Drobakha VE, Shestakov VV. Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4-17. (In Russ.) doi: 10.14412/2074-2711-2019-3S-4-17
41. Kulesh AA, Drobakha VE, Shestakov VV. Cerebral small vessel disease: classification, clinical manifestations, diagnosis, and features of treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):4-17. (In Russ.) doi: 10.14412/2074-2711-2019-3S-4-17
42. Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23
43. Novosadova OA, Grigor'eva VN. Cerebral amyloid angiopathy and hypertensive cerebral microangiopathy. Differential diagnosis. Nevrologicheskii vestnik. 2019;51(2):72-9. (In Russ.)
44. Novosadova OA, Grigor'eva VN. Cerebral amyloid angiopathy and hypertensive cerebral microangiopathy. Differential diagnosis. Nevrologicheskii vestnik. 2019;51(2):72-9. (In Russ.)
45. Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.
46. Perry LA, Rodrigues M, Al-Shahi Salman R, Samarasekera N. Incident Cerebral Microbleeds After Intracerebral Hemorrhage. Stroke. 2019 Aug;50(8):2227-2230. doi: 10.1161/STROKEAHA.118.023746. Epub 2019 Jun 17.
47. Perry LA, Rodrigues M, Al-Shahi Salman R, Samarasekera N. Incident Cerebral Microbleeds After Intracerebral Hemorrhage. Stroke. 2019 Aug;50(8):2227-2230. doi: 10.1161/STROKEAHA.118.023746. Epub 2019 Jun 17.
48. Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.
49. Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4.
50. Pasi M, Pongpitakmetha T, Charidimou A, et al. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy. Stroke. 2019 Jul;50(7):1727-1733. doi: 10.1161/STROKEAHA.119.024843. Epub 2019 Jun 4.
51. Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11
52. Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.
53. Blanc C, Viguier A, Calviere L, et al. Underlying Small Vessel Disease Associated With Mixed Cerebral Microbleeds. Front Neurol. 2019 Oct 23;10:1126. doi: 10.3389/fneur.2019.01126. eCollection 2019.
54. Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.
55. Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.
56. Lin J, Piran P, Lerario MP, et al. Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage. Stroke. 2020 Feb;51(2):644-647. doi: 10.1161/STROKEAHA.119.028009. Epub 2019 Dec 10.
57. Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.
58. Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37
59. Ostroumova TM, Ostroumova OD, Parfenov VA. Early signs of damage to the brain as a target organ in hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 32-7. (In Russ.) doi: 10.14412/2074-2711-2019-3S-32-37
60. Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.
61. Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34
62. Kulesh AA, Drobakha VE, Sobyanin KV, et al. Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):26-34. (In Russ.) doi: 10.14412/2074-2711-2019-3-26-34
63. Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.
64. Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23
65. Ostroumova TM, Parfenov VA, Ostroumova OD, et al. Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):17-23. (In Russ.) doi: 10.14412/2074-2711-2018-1-17-23
66. Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.
67. Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.
68. Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An ImagingPathologic Study of Concept Validation. JAMA Neurol. 2016 Aug 1;73(8):994-1001. doi: 10.1001/jamaneurol.2016.0832.
69. Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.
70. Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.
71. Rodrigues MA, Samarasekera N, Lerpiniere C, et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 2018 Mar; 17(3):232-240. doi: 10.1016/S1474-4422(18)30006-1. Epub 2018 Jan 10.
72. Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.
73. Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11
74. Kulesh AA, Drobakha VE, Shestakov VV. Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):4-11. (In Russ.) doi: 10.14412/2074-2711-2018-3-4-11
75. Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88
76. Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.
77. Tsai HH, Pasi M, Tsai LK, et al. Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2020 Jan;51(1):202-208. doi: 10.1161/STROKEAHA.119.026235. Epub 2019 Nov 15.
78. Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.
79. Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.
80. Charidimou A, Boulouis G, Xiong L, et al. Cortical Superficial Siderosis Evolution. Stroke. 2019 Apr;50(4):954-962. doi: 10.1161/STROKEAHA.118.023368.
81. Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.
82. Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.
83. Charidimou A, Imaizumi T, Moulin S, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a metaanalysis. Neurology. 2017 Aug 22;89(8):820-829. doi: 10.1212/WNL.0000000000004259. Epub 2017 Jul 26.
84. Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.
85. Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.
86. Charidimou C, Boulouis G, Roongpiboonsopit D, et al. Cortical superfical siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.
87. Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.
88. Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.
89. Charidimou A, Boulouis G, Roongpiboonsopit D, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20.
90. Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.
91. Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.
92. Casolla B, Moulin S, Kyheng M, et al. FiveYear Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage. Stroke. 2019 May;50(5):1100-1107. doi: 10.1161/STROKEAHA.118.024449.
93. Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.
94. Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.
95. Steiner T, Weitz JI, Veltkamp R. Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. Stroke. 2017 May;48(5):1432-1437. doi: 10.1161/STROKEAHA.116.013343. Epub 2017 Apr 11.
96. Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.
97. Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88
98. Yanishevskii SN. Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S): 82-8. (In Russ.) doi: 10.14412/2074-2711-2019-3S-82-88
99. Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.
100. Bower MM, Sweidan AJ, Shafie M, et al. Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke. 2019 Feb; 50(2):529-536. doi: 10.1161/STROKEAHA.118.023840.
101. Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.
102. Wilson D, Ambler G, Shakeshaft C, et al.; CROMIS-2 Collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16.
103. Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.
104. Marti-Fabregas J, Medrano-Martorell S, Merino E, et al; HERO Study Investigators. MRI predicts intracranial hemorrhage in patients who receive longterm oral anticoagulation. Neurology. 2019 May 21;92(21):e2432-e2443. doi: 10.1212/WNL.0000000000007532. Epub 2019 Apr 19.
105. Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.
106. Seiffge DJ, Goeldlin MB, Tatlisumak T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol. 2019 Dec;266(12): 3126-3135. doi: 10.1007/s00415-019-09536-1. Epub 2019 Sep 20.
107. Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.
108. Lioutas VA, Goyal N, Katsanos AH, et al. Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage. Stroke. 2018 Oct; 49(10):2309-2316. doi: 10.1161/STROKEAHA.118.021979.
109. Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.
110. Seiffge DJ, Curtze S, Dequatre-Ponchelle N, et al. Hematoma location and morphology of anticoagulation-associated intracerebral hemorrhage. Neurology. 2019 Feb 19;92(8):e782-e791. doi: 10.1212/WNL.0000000000006958. Epub 2019 Jan 23.
111. Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.
112. Gerner ST, Kuramatsu JB, Sembill JA, et al. Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke. 2019 Jun;50(6):1392-1402. doi: 10.1161/STROKEAHA.118.023492. Epub 2019 May 16.
Review
For citations:
Kulesh A.A. Current approaches to diagnosing in intracerebral hemorrhage. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):4-11. https://doi.org/10.14412/2074-2711-2020-2-4-11
Views: 980
Email this article 